|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1776 Wilson Blvd. |
Address2 | |
City | Arlington |
State | VA |
Zip Code | 22209 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 26672-12
|
||||||||
|
6. House ID# 302390000
|
TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: David M. Fitzsimmons |
Date | 01/18/2013 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
S. 27, Preserve Access to Affordable Generics Act
S. 31, Prescription Drug and Health Improvement Act of 2011
S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011
H.R. 147, Prescription Drug Affordability Act
H.R. 741, To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs
H.R. 979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
H.R. 1971, Pharmacy Competition and consumer Choice Act of 2011
H.R. 2128, STEAM (Stripping the E-Prescribe Arbitrary Mandates) Act of 2011
S. 1058, Pharmacy Competition and Consumer Act of 2011
S. 1356, Affordable Medicines Utilization Act of 2011
S. 1584, Drug Safety and Accountability Act of 2011
H.R. 3026, Safeguarding America's Pharmaceuticals Act of 2011
S. 2002, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of Internet Pharmacies
S. 3187, FDA Safety and Innovation Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steve |
Anderson |
|
|
|
Heidi |
Ecker |
|
|
|
Diane |
Darvey |
|
|
|
Anne |
Foley |
|
|
|
Carol |
Kelly |
|
|
|
Julie |
Khani |
|
|
|
Kevin |
Nicholson |
|
|
|
Julie |
Philp |
|
|
|
Marc |
Schloss |
|
|
|
Thomas |
O'Donnell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1406, Fairness to Pet Owners Act of 2011
H.R. 2248, Medicare Prescription Drug Price Negotiation Act of 2011
S. 1099, Help Efficient, Accessible, Low Cost, Timely Healthcare (HEALTH) Act of 2011
H.R. 436, Health Care Cost Reduction Act of 2012
S. 1855, Pandemic All-hazards Preparedness Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steve |
Anderson |
|
|
|
Heidi |
Ecker |
|
|
|
Anne |
Foley |
|
|
|
Carol |
Kelly |
|
|
|
Julie |
Khani |
|
|
|
Kevin |
Nicholson |
|
|
|
Julie |
Philp |
|
|
|
Marc |
Schloss |
|
|
|
Diane |
Darvey |
|
|
|
Thomas |
O'Donnell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011
H.R. 1266, Fraudulent Prescription Prevention Act of 2011
H.R. 1925, Prescription Drug Abuse Prevention and Treatment Act of 2011
S. 507, Prescription Drug Abuse Prevention and Treatment Act of 2011
S. 882, STOP Act
S.968, Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011
S. 1002, Safe Doses Act
S. 1612, Targeting Transnational Drug Trafficking Act of 2011
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Drug Enforcement Administration (DEA), Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steve |
Anderson |
|
|
|
Diane |
Darvey |
|
|
|
Heidi |
Ecker |
|
|
|
Anne |
Foley |
|
|
|
Carol |
Kelly |
|
|
|
Julie |
Khani |
|
|
|
Kevin |
Nicholson |
|
|
|
Marc |
Schloss |
|
|
|
Julie |
Philp |
|
|
|
Thomas |
O'Donnell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 891, Medication Therapy Management Benefits Act of 2011
S. 44, Medicare Prescription Drug Price Negotiation Act of 2011
S. 274, Medication Therapy Management Empowerment Act of 2011
S. 1356, A Bill to amend title XIX of the Social Security Act to encourage states to increase generic drug utilization under Medicaid
H.R. 4215, Medicare Pharmacy Transparency and Fair Auditing Act
S. 1251, Medicare and Medicaid FAST Act
H.R. 1936, Medicare Access to Diabetes Supplies Act of 2011
H.R. 8, American Taxpayer Relief Act of 2012
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steve |
Anderson |
|
|
|
Diane |
Darvey |
|
|
|
Heidi |
Ecker |
|
|
|
Anne |
Foley |
|
|
|
Carol |
Kelly |
|
|
|
Julie |
Philp |
|
|
|
Marc |
Schloss |
|
|
|
Kevin |
Nicholson |
|
|
|
Julie |
Khani |
|
|
|
Thomas |
O'Donnell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R. 605, Patients' Freedom to Choose Act
S. 312, Patients' Freedom to Choose Act
H.R. 450, Restoring Assistance for Families and Seniors Health Expenses Act of 2011
H.R. 2529, Restoring Access to Medication Act
S. 1098, Family and Retirement Health Investment Act of 2011
S. 1368, Restoring Access to Medication Act
H.R. 2010, Family and Retirement Health Investment Act of 2011
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Internal Revenue Service (IRS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steve |
Anderson |
|
|
|
Diane |
Darvey |
|
|
|
Heidi |
Ecker |
|
|
|
Anne |
Foley |
|
|
|
Carol |
Kelly |
|
|
|
Julie |
Khani |
|
|
|
Kevin |
Nicholson |
|
|
|
Marc |
Schloss |
|
|
|
Julie |
Philp |
|
|
|
Thomas |
O'Donnell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
H.R. 1092, Military Retirees Health Care Protection Act
H.R. 1285, Military Health Care Affordability Act
H.R. 1540, National Defense Authorization Act for Fiscal Year 2012
S. 981, National Defense Authorization Act for Fiscal Year 2012
H.R. 4310, National Defense Authorization Act for Fiscal Year 2013
S. 2467, National Defense Authorization Act for Fiscal Year 2013
S. 1274, Department of Defense Authorization Act for Fiscal Year 2012
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steve |
Anderson |
|
|
|
Diane |
Darvey |
|
|
|
Heidi |
Ecker |
|
|
|
Anne |
Foley |
|
|
|
Carol |
Kelly |
|
|
|
Julie |
Khani |
|
|
|
Kevin |
Nicholson |
|
|
|
Marc |
Schloss |
|
|
|
Julie |
Philp |
|
|
|
Thomas |
O'Donnell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BAN
16. Specific lobbying issues
S. 575, Debit Interchange Fee Study Act of 2011
H.R. 1081, Consumers Payment System Protection Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Federal Reserve System
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steve |
Anderson |
|
|
|
Heidi |
Ecker |
|
|
|
Diane |
Darvey |
|
|
|
Anne |
Foley |
|
|
|
Carol |
Kelly |
|
|
|
Julie |
Khani |
|
|
|
Kevin |
Nicholson |
|
|
|
Marc |
Schloss |
|
|
|
Julie |
Philp |
|
|
|
Thomas |
O'Donnell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |